Potential Lymphoma Drug, Aplidin, May Become Available in 12 Asian Countries
News
PharmaMar has signed an agreement with Singapore-based Specialised Therapeutics Asia to market Aplidin (plitidepsin), a marine-based anti-tumor compound under development for the treatment of hematological tumors, including lymphoma, in 12 Southeast Asian ... Read more